Therapeutic plasma exchange without anticoagulation: Single‐center experience
Authors:
- Eduardo Zúñiga‐RodríguezEZEduardo Zúñiga‐Rodríguez
- Danna PeñaDPDanna Peña
- Juliana MantillaJMJuliana Mantilla
- Juan Camilo Castellanos‐De La HozJHJuan Camilo Castellanos‐De La Hoz
- Maria Patricia Carvajal‐AbrilMCMaria Patricia Carvajal‐Abril
- Isabel Cristina Saravia BermeoIBIsabel Cristina Saravia Bermeo
- Alejandra Molano‐TriviñoAMAlejandra Molano‐Triviño
- 5 November 2024
- journal article
- research article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 30 (5) , 641-648
Abstract
Background: Membrane therapeutic plasma exchange (mTPE) is indicated for treating autoimmune, neurological, hematological, and renal diseases. Few studies have assessed the effectiveness and safety of this technique, especially when no anticoagulants are added. This study evaluated the outcomes of mTPE without anticoagulation at a single center.Methods: Based on registry data, this retrospective cohort study included adult patients treated with mTPE without anticoagulants for different indications.Results: From October 2021 to October 2022, 46 patients received 385 mTPE treatments. The primary diagnosis leading to the intervention was humoral rejection of the kidney transplant (59.2%). Most procedures (62.1%) were performed in the inpatient department. The complication rate was 1.3%, with 2.1% of patients experiencing device coagulation. Only five patients experienced mild adverse events. There were no cases of mortality.Conclusions: When indicated, mTPE without anticoagulation is a safe hospital technique. Protocols are needed to guide the use and monitoring of this therapy.Keywords
Funding Information
- Baxter International
This publication has 23 references indexed in Scilit:
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special IssueJournal of Clinical Apheresis, 2023
- Plasma exchange in the intensive care unit: a narrative reviewIntensive Care Medicine, 2022
- Comparison of centrifugal and membrane filtration modalities on therapeutic plasma exchangeJournal of Clinical Apheresis, 2022
- Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trialInternational Journal of Antimicrobial Agents, 2021
- Fibrinogen reconstitution after therapeutic apheresis: Comparison of double‐filtration plasmapheresis, plasma exchange, and immunoadsorptionJournal of Clinical Apheresis, 2021
- Application of regional citrate anticoagulation in membrane therapeutic plasma exchangeInternational Urology and Nephrology, 2020
- Membrane‐based therapeutic plasma exchange (mTPE): Technical and clinical experienceJournal of Clinical Apheresis, 2017
- Membrane therapeutic plasma exchange with and without heparin anticoagulationJournal of Clinical Apheresis, 2017
- Plasma exchange in the intensive care unit: Technical aspects and complicationsJournal of Clinical Apheresis, 2017
- Experience in therapeutic plasma exchange by membrane filtration at an academic center in Colombia: Registry of the first 500 sessionsJournal of Clinical Apheresis, 2015